CDH2 and neoplasm: Another study showed that a loss of function in PARP-1 activated the epithelial–mesenchymal transition pathway through the increased expression of N-cadherin and ZEB-1 and the decreased expression of E-cadherin and β-catenin, which promote tumour progression through the TGF-β signalling pathway [47].